rHb1: SMTG began a Phase I trial of rHb1.1 in 50 patients who have been on hemodialysis

Somatogen Inc. (SMTG), Boulder, Colo. Product: rHb1.1 recombinant hemoglobin Indication: Anemia from end-stage kidney disease Status: SMTG began a Phase I trial of rHb1.1 in 50 patients who have been ...